The Court of Appeal has held that a patent for a new dosage regime for a pharmaceutical previously suggested as a treatment for the specified disease was novel.
The Court of Appeal has held that a patent for a new dosage regime for a pharmaceutical previously suggested as a treatment for the specified disease was novel.